Ligand Pharmaceuticals Incorporated (LGND): Narxning daromadga nisbati

Ligand Pharma (LGND) brendining ramzi va logotipi

Savdo mojarolari fonidagi daromad koeffitsiyenti dinamikasi xalqaro patentlash bilan bog'liq qiyinchiliklarni ochib bermoqda, biroq 24.30 darajasi yangi qiymatlarni qayd etib, Ligand Pharmaceuticals (LGND) barqarorligini tasdiqlamoqda. Ligand Pharmaceuticals hamkorlar bilan litsenziyalash shartnomalari orqali daromad keltirib, ilmiy sinergiya yaratadi. Bundan tashqari, texnologiya transferining xususiyatlari logistik xatarlarni minimallashtirib, hatto makroiqtisodiy beqarorlik sharoitida ham biznes barqarorligini ta'minlaydi.

Ligand Pharmaceuticals (LGND): P/S multiplikatori 04.07.2022dan 16.11.2026gacha

Ligand (LGND) kompaniyasi koʻrsatkichlari kesimi va tahlili

- birja kapitallashuvi ma'lumotlari:
Kompaniyaning umumiy tahlili:Ligand Pharma (LGND)
ligand.com brend mahsuloti

Aktivlarning ishonchliligini baholash sotuvlar birligi uchun to'lanadigan premiumni aniqlaydigan bozor kapitalizatsiyasining yillik daromadga nisbatini tahlil qilishdan boshlanadi. Ligand Pharmaceuticals (LGND) uchun ushbu hisob-kitob minimal xarajatlarga ega royalti modelining samaradorligini tasdiqlaydi; shuning uchun, tarixiy P/S darajalaridan har qanday chetga chiqish barqaror pul oqimlarining haddan tashqari yuqori baholanganini yoki yaqinlashib kelayotgan narx korreksiyasini anglatadi.

Ligand Pharmaceuticals kimlar bilan raqobatlashadi

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|amneal.com (AMRX) - Kapitalizatsiyaning daromadga nisbati|Perrigo (PRGO) - Narxning daromadga nisbati|ALVO (Alvotech S.A.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati LQDA|P/S multiplikatori Galapagos Corp|Narxning daromadga nisbati ANI Pharma (ANIP)|P/S multiplikatori MannKind Corporation (MNKD)|Narxning daromadga nisbati Amphastar Pharmaceuticals Inc AMPH|P/S multiplikatori Pacira PCRX|ARS Pharmaceuticals Inc - P/S multiplikatori|TBPH - P/S multiplikatori|AQST (Aquestive Therapeutics) - Kapitalizatsiyaning daromadga nisbati|scPharmaceuticals, Inc. (SCPH) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati TECX|P/S multiplikatori Tonix Pharma|Kapitalizatsiyaning daromadga nisbati SXTC (SXT Pharmaceuticals)|EPRX: Narxning sotuvga nisbati|BioHarvest Sciences - Kapitalizatsiyaning daromadga nisbati|EXOZ: Kapitalizatsiya va daromad nisbati|ORMP - Narxning daromadga nisbati|ENTX: Narxning daromadga nisbati|HYFT: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati ABVC BioPharma Inc|CPIX (Cumberland Corp) - P/S multiplikatori|P/S multiplikatori quantumbiopharma.com|P/S multiplikatori FGEN|Kapitalizatsiyaning daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|P/S multiplikatori RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Narxning sotuvga nisbati|RLYB: Kapitalizatsiyaning daromadga nisbati|lexariabioscience.com (LEXX) - Kapitalizatsiyaning daromadga nisbati|Pulmatrix Inc (PULM) - Narxning daromadga nisbati|PTHL: Kapitalizatsiyaning sotish hajmiga nisbati|APM (Aptorum Group Ltd) - P/S multiplikatori|Lyra Therapeutics Inc (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|Kapitalizatsiyaning sotish hajmiga nisbati TNFA|cbdMD, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PRFX|Altamira Therapeutics Ltd. - P/S multiplikatori|LIPO: Narxning daromadga nisbati|OPTN: P/S multiplikatori|Narxning sotuvga nisbati PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - P/S multiplikatori|PTPI (Petros Pharmaceuticals Inc) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)